Papers

1

Total Citations

7

H-Index

1

About

Daniel Ho is a clinical researcher whose work has been pivotal in guiding surgical practice during the COVID-19 pandemic. His primary research areas include perioperative medicine, surgical safety, and healthcare system resilience during infectious disease outbreaks. Ho’s most notable contribution is his landmark study evaluating 30-day mortality for 500 patients undergoing non-emergency surgery in a COVID-19 cold site within a multicentre regional surgical network. This work demonstrated that with rigorous preoperative screening and dedicated infection-control protocols, elective surgery could be performed safely even during a global health crisis—a finding that directly informed clinical guidelines worldwide. The study, which has garnered 7 citations, provided critical evidence that helped prevent the complete shutdown of surgical services, thereby mitigating the collateral damage of cancelled procedures on patient outcomes. Ho’s research has been instrumental in shaping pandemic-era surgical triage, balancing the risks of COVID-19 exposure against the harms of delayed care. His work continues to influence how hospitals maintain essential surgical capacity during public health emergencies, making him a key voice in perioperative crisis management.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Evaluation of 30-day mortality for 500 patients undergoing non-emergency surgery in a COVID-19 cold site within a multicentre regional surgical network during the COVID-19 pandemic
7 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: University College London Hospitals NHS Foundation Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago